Health
Prevalence, determinants, and outcomes of SARS‐COV‐2 infection among cancer patients. A population‐based study in northern Italy – Wiley
SARS-CoV-2 infection risk among cancer patients as compared to cancer-free individuals has been poorly investigated on a population-basis….

1 INTRODUCTION
Biologic (e.g., immune depression related to anticancer treatments) and non-biologic factors (e.g., most people with cancer needs to interface with health institutions) have been hypothesized to expose cancer patients at higher risk of severe…
Continue Reading